Grafa News and Videos — Page 752

Nuvation Bio (NYSE:NUVB) reported updated long-term Phase 2 data for safusidenib in chemotherapy- and radiotherapy-naïve grade 2 IDH1-mutant glioma.

VERAXA Biotech (NASDAQ:VRXA) received Scientific Advice from Germany’s Paul-Ehrlich-Institute on the biological rationale and non-clinical development plan for its lead BiTAC-TCE programme.

Dyne Therapeutics (NASDAQ:DYN) received FDA acceptance of its Biologics License Application for z-rostudirsen, an investigational treatment for Duchenne muscular dystrophy amenable to exon 51 skipping.

Magnolia Oil & Gas (NYSE:MGY) agreed to acquire WildFire Energy for approximately $4.06 billion, including WildFire’s debt, expanding its South Texas oil and gas position.

Immunome (NASDAQ:IMNM) dosed the first patient in a Phase 1 trial of IM-3050 for FAP-expressing advanced solid tumours.

IREN (NASDAQ:IREN) raised its year-end 2026 AI Cloud annualized run-rate revenue (ARR) target to over $4 billion, up from its previous target of $3.7 billion.

Highway Holdings (NASDAQ:HIHO) reported first-quarter fiscal 2027 revenue of approximately $2 million, representing a 29.2% increase compared to the same period last year.

GE Aerospace (NYSE:GE) announced at the Farnborough International Airshow that it has successfully conducted the world’s first hybrid electric flight above 30,000 feet.

Boeing (NYSE:BA) and Philippine Airlines announced that the flag carrier has committed to order up to 20 Boeing 787 Dreamliner jets.

IFF (NYSE:IFF) — a global leader in flavors, fragrances, and health and biosciences — announced that it has entered into an agreement with SuanNutra to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities.